5,0
4 dic 2023
Dipendente attuale, più di un anno
Cambridge, MA
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
- Friendly and knowledgeable colleagues and leaders - Focus on helping patients through scientifically sound therapeutics - Strong scientific background across all levels of leadership
Svantaggi
- Not as commercially oriented as big pharma - Financially ok for a few years but need additional revenue streams to maintain the operation - Certain decision-making and problem-solving processes are inefficient because Germany makes the final decision. US IT can't even restart the WiFi without approval and help from Germany